WallStreetZenWallStreetZen

NASDAQ: TMDX
Transmedics Group Inc Earnings & Revenue

TMDX past revenue growth

How has TMDX's revenue growth performed historically?
Company
158.53%
Industry
8.63%
Market
18.28%
TMDX's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
TMDX's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Market Performance
TMDX's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

TMDX earnings and revenue history

Current Revenue
$241.6M
Current Earnings
-$25.0M
Current Profit Margin
-10.4%

TMDX Return on Equity

Current Company
-16.6%
Current Industry
11.7%
Current Market
188%
TMDX's Return on Equity (-16.6%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when TMDX announces earnings.

TMDX Return on Assets

Current Company
-4.2%
Current Industry
5.9%
TMDX is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

TMDX Return on Capital Employed

Current Company
-2.44%
Current Industry
9.2%
TMDX has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

TMDX vs Medical Device Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
TMDX$241.62M-$6.66M-$25.03M+79.36%N/A
PRCT$136.19M-$98.08M-$105.90M+116.76%N/A
CNMD$1.24B$136.80M$64.46M+7.68%+7.69%
LIVN$1.12B$136.06M$2.87M+0.54%N/A
QDEL$3.12B$625.20M$13.20M+43.98%N/A

TMDX earnings dates

Next earnings date
Apr 29, 2024

Transmedics Group Earnings & Revenue FAQ

What were TMDX's earnings last quarter?

On Invalid Date, Transmedics Group (NASDAQ: TMDX) reported Q4 2023 earnings per share (EPS) of $0.12, up 160% year over year. Total Transmedics Group earnings for the quarter were $4.03 million. In the same quarter last year, Transmedics Group's earnings per share (EPS) was -$0.20.

If you're new to stock investing, here's how to buy Transmedics Group stock.

What was TMDX's earnings growth in the past year?

As of Q1 2024, Transmedics Group's earnings has grown year over year. Transmedics Group's earnings in the past year totalled -$25.03 million.

What is TMDX's earnings date?

Transmedics Group's earnings date is Invalid Date. Add TMDX to your watchlist to be reminded of TMDX's next earnings announcement.

What was TMDX's revenue last quarter?

On Invalid Date, Transmedics Group (NASDAQ: TMDX) reported Q4 2023 revenue of $81.17 million up 158.72% year over year. In the same quarter last year, Transmedics Group's revenue was $31.38 million.

What was TMDX's revenue growth in the past year?

As of Q1 2024, Transmedics Group's revenue has grown 158.53% year over year. This is 149.9 percentage points higher than the US Medical Devices industry revenue growth rate of 8.63%. Transmedics Group's revenue in the past year totalled $241.62 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.